Valencia Quintero, J. S., & Castillo, D. (2023). Venglustat, Lanreotide Acetate, and Tolvaptan as therapeutic options for the treatment of autosomic dominant polychistic kidney disease: a narrative review. Interdisciplinary Journal of Epidemiology and Public Health, 3(2), e-7246. https://doi.org/10.18041/2665-427X/ijeph.2.7246 (Original work published 2020)